AK Medical
AK Medical, officially known as AK Medical Holdings Limited, is a leading player in the orthopaedic medical device industry, headquartered in China. Established in 2002, the company has made significant strides in the development and manufacturing of innovative orthopaedic implants and instruments, primarily serving the Asia-Pacific region and expanding its reach globally. Specialising in joint replacement and trauma products, AK Medical is recognised for its commitment to quality and advanced technology, which sets its offerings apart in a competitive market. The company has achieved notable milestones, including various certifications and partnerships that enhance its market position. With a focus on research and development, AK Medical continues to deliver unique solutions that improve patient outcomes and solidify its reputation as a trusted name in orthopaedics.
DitchCarbon Score
How does AK Medical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
AK Medical's score of 19 is lower than 88% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
AK Medical's reported carbon emissions
In 2022, AK Medical reported total carbon emissions of approximately 1,514,900 kg CO2e from Scope 2 (indirect emissions) and 99300 kg CO2e from Scope 1 (direct emissions). The company also disclosed Scope 3 emissions amounting to about 3,693,100 kg CO2e. The emissions data for 2023 is not available, but the company has shown a consistent approach to monitoring its carbon footprint over the years. AK Medical has not set specific reduction targets or initiatives as part of its climate commitments, nor does it appear to have cascaded any targets from a parent organisation. The company’s emissions data is self-reported and reflects its commitment to transparency in environmental impact reporting. Overall, AK Medical's emissions profile indicates a significant reliance on indirect emissions, highlighting the importance of addressing Scope 2 emissions in its sustainability strategy. The absence of formal reduction targets suggests an opportunity for the company to enhance its climate commitments in alignment with industry standards.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | |
|---|---|---|
| Scope 1 | 242,600 | 00,000 |
| Scope 2 | 1,185,000 | 0,000,000 |
| Scope 3 | 1,427,600 | 0,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
AK Medical is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
